Medicine & Life Sciences
5'-methylthioadenosine phosphorylase
72%
Adenine
6%
Adenocarcinoma of Lung
6%
Adoptive Transfer
6%
atezolizumab
6%
Biomarkers
6%
Carcinoma
30%
Cell- and Tissue-Based Therapy
33%
Cisplatin
35%
Clinical Trials
17%
Cold Temperature
31%
DNA Damage
5%
durvalumab
7%
Enzymes
22%
Folic Acid Antagonists
48%
Genes
21%
Hydronephrosis
5%
Immunosuppressive Agents
9%
Immunotherapy
30%
Interferon-gamma
10%
Interleukin-7
45%
Ipilimumab
58%
Leukocytes
6%
Macrophages
8%
Melanoma
16%
Neoadjuvant Therapy
5%
Neoplasm Metastasis
7%
Neoplasms
87%
Nivolumab
15%
Pemetrexed
46%
Perforin
7%
Prostate
19%
Prostatic Neoplasms
27%
Protein-Arginine N-Methyltransferases
10%
purine
13%
Purinergic P1 Receptors
8%
Safety
5%
Synthetic Lethal Mutations
8%
T-Lymphocytes
64%
Therapeutics
41%
tremelimumab
7%
Tumor Microenvironment
54%
Tumor-Infiltrating Lymphocytes
26%
Urologic Neoplasms
10%
Physics & Astronomy
activation
9%
adenines
11%
biomarkers
7%
cancer
54%
cells
6%
cultured cells
10%
damage
6%
deletion
8%
deoxyribonucleic acid
7%
enzymes
9%
immunosuppression
11%
lethality
13%
leukocytes
16%
lungs
9%
nucleotides
10%
phenotype
8%
pretreatment
6%
proportion
5%
purines
26%
sensitivity
10%
stratification
6%
synthesis
6%
therapy
100%
tumors
83%